Thyroid Hormone Sensitivity and Non-Alcoholic Fatty Liver Disease in Diabetic Patients
Author Information
Author(s): Zhang Xiaowen, Liu Jie, Wang Qian, Han Chen, Yan Yu, Xiang Xinyue, Shen Shanmei, Feng Wenhuan
Primary Institution: Nanjing Drum Tower Hospital, Nanjing University School of Medicine
Hypothesis
Is there an association between thyroid hormone sensitivity and the risk of developing non-alcoholic fatty liver disease (NAFLD) in diabetic patients?
Conclusion
Impaired sensitivity to thyroid hormone is linked to a higher risk of developing NAFLD but a lower risk of advanced fibrosis in diabetic individuals.
Supporting Evidence
- TFQI was associated with an increased risk of NAFLD in diabetic patients.
- Diabetic status significantly affected NAFLD development.
- TFQI was linked to a lower risk of advanced fibrosis in diabetic patients.
Takeaway
If you have diabetes, your body's response to thyroid hormones can affect your risk of liver problems. This study found that people with diabetes who don't respond well to thyroid hormones are more likely to develop fatty liver disease.
Methodology
The study analyzed data from 26,413 participants in a health screening program and 8,246 hospitalized patients with type 2 diabetes, using multivariate logistic regression to assess the association between thyroid hormone sensitivity indices and NAFLD.
Potential Biases
Potential biases include missing data and reliance on self-reported medical history.
Limitations
The study is retrospective, relies on ultrasound for NAFLD diagnosis, and cannot establish causality.
Participant Demographics
The study included 57.7% male participants, with a mean age of 48.3 years in the health screening cohort and 56.96 years in the hospitalized cohort.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 1.15–1.75
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website